Skip to content
Recall Observatory FDA recall evidence

Drug product

Olopatadine HCl Ophthalmic Solution, USP 0.2%, 2.5 mL per bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-305-12

D-0149-2023

October 13, 2022

Class II

Product summary

Firm
Akorn, Inc.
Event
Event 90948
Status
Ongoing
Classification
Class II
Quantity
173,928 bottles
Official record key
drug-enforcement:D-0149-2023

Official wording

Reason: CGMP Deviations:

Code information: Lot: 0L48A, EXP 10/31/2022; 0L55A, EXP 10/31/2022; 1C75A, EXP 2/28/2023; 1E18A, 1E20A , EXP 4/30/2023;

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations